FY'26 Q3 Earnings Presentation MARCH 9, 2026 | © 2025 Korn Ferry Safe Harbor Statement FORWARD-LOOKING STATEMENTS Statements in this presentation that relate to goals, strategies, future plans and expectations are based on Korn Ferry's current expectations. You are cautioned not to place undue reliance on such statements. Actual results in future periods may differ materially from those currently expected because of a number of risks and uncertainties. For a detailed description of many of those risks and u ...

Fourth Quarter and Full Year 2025 Results Yair Nechmad CEO & Co-Founder Sagit Manor CFO Aaron Greenberg CSO 3 3 March 9, 2026 1 Important Disclosure Forward-looking statements, risk factors, and non-GAAP financial measures referenced in this presentation 2 • This presentation is intended to provide general information only and is not, and should not be considered, as an offer to purchase or sell the Company's securities, or a proposal to receive such offers. In addition, this presentation is not an offer to ...

First Quarter 2026 Financial Results & Business Update A rendering of a 50-MW FuelCell Energy data center installation © 2026 FuelCell Energy © 2026 FuelCell Energy 1 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding future events or our future financial performance that involve certain contingencies and uncertainties. The forward-looking statements include, without li ...

Heritage Insurance (NYSE:HRTG) Q4 2025 Earnings call March 09, 2026 09:00 AM ET Speaker4 Good morning. Welcome to the Heritage Insurance Holdings fourth quarter and full year 2025 earnings conference call. Please note today's event is being recorded. I would now like to turn the conference over to Kirk Lusk, Chief Financial Officer for the company. Please go ahead, sir. Speaker2 Good morning, and thank you for joining us today. We invite you to visit the investors section of our website, investors.heritagep ...

Neurocrine Biosciences (NasdaqGS:NBIX) 2026 Conference March 09, 2026 08:40 AM ET Speaker0Thanks for joining us. I'm Marc Goodman, one of the biopharma analysts at Leerink, and it's great to have Neurocrine here. We have Matt Abernathy, who's the CFO, and Todd Tushla, who's the IR guy. Thank you very much for joining us. Matt, I'll give you a chance just to make an opening comment, maybe not too long, but, you know, just kind of set the stage.Speaker1I'll try to run out the clock.Speaker0YeahSpeaker1if that ...

CVS Health (NYSE:CVS) 2026 Conference March 09, 2026 08:40 AM ET Speaker0Great. Good morning, everyone. Welcome to this session of the Leerink Global Healthcare Conference. I'm Mike Cherny, the healthcare tech distribution analyst. Pleased to have CVS Health with me. Prem Shah, Group President, kinda does everything now. Larry McGrath, Chief of Strategy, also does everything right now. Tom Zoltowski, who runs the IR function, in the back with us. I have a ton of questions. We're just gonna start to jump rig ...

Intellia Therapeutics (NasdaqGM:NTLA) 2026 Conference March 09, 2026 08:40 AM ET Speaker2Perfect. Thank you. Welcome back to the next session of this year's Global Healthcare Conference here in Miami. Once again, Mani Foroohar, senior analyst at Leerink Partners. I'm hosting John Leonard and Ed Dulac from Intellia Therapeutics. Welcome to Miami, guys.Speaker1Good to be here.Speaker0Thanks.Speaker2I feel like I should sing that at some point. No one needs to be punished with my karaoke voice. Before we dive ...

Camp4 Therapeutics (NasdaqGM:CAMP) 2026 Conference March 09, 2026 08:40 AM ET Speaker1Welcome everyone to the Global Healthcare Conference of Leerink Partners for 2026. I'm Liliana Sango, and I'm joined today by Josh Mendelsohn, the CEO of CAMP4. Josh, welcome.Speaker0Great. Thank you for having us here.Speaker1Well, thanks for coming. Maybe we can just dive right in. I'm just gonna give you some time so you can give us an overview of your technology platform, given how differentiated it is from most of the ...

NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2026 Conference March 09, 2026 08:40 AM ET Speaker2Okay, great. I think we're at time, I'll kick it off. Hey, everybody. I'm Roanna Ruiz, one of the Senior Biotech Analysts here at Leerink Partners. Just wanna welcome everybody to our global healthcare conference, it's my pleasure to introduce NewAmsterdam Pharma. I've got the CEO, Michael Davidson, with me here, also the CFO, Ian Somaiya. Thanks so much for joining us.Speaker1Thanks for having us. Yeah.Speaker0Go ...

Spyre Therapeutics (NasdaqGS:SYRE) 2026 Conference March 09, 2026 08:40 AM ET Speaker2Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name's Tom Smith. I'm one of the senior biotech analysts here at Leerink, and it's my pleasure to introduce our next company, Spyre Therapeutics, and their management team, led by CEO Cameron Turtle and CMO Sheldon Sloan. Gentlemen, thanks for joining us.Speaker0Thanks for having us.Speaker2This is one of our top pic ...